General American Investors CO Inc Regeneron Pharmaceuticals, Inc. Transaction History
General American Investors CO Inc
- $1.4 Billion
- Q1 2024
A detailed history of General American Investors CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, General American Investors CO Inc holds 14,576 shares of REGN stock, worth $14.3 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
14,576
Previous 16,576
12.07%
Holding current value
$14.3 Million
Previous $14.6 Million
3.63%
% of portfolio
1.0%
Previous 1.15%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$8.75 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.4 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.57 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.75 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.56 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $105B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...